Editorial comment on: Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.
von der Maase
Hans
H
Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. hans.von.der.maase@rh.regionh.dk
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use* / Q000633:toxicity; D016190:Carboplatin / Q000008:administration & dosage; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage; D016019:Survival Analysis; D014523:Urethral Neoplasms / Q000188:drug therapy* / Q000401:mortality; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality
D016190:Carboplatin; D017239:Paclitaxel